Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.44B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$433M |
| 4 |
Johnson & Johnson
JNJ
|
+$349M |
| 5 |
Amazon
AMZN
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$873M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$799M |
| 3 |
Colgate-Palmolive
CL
|
+$602M |
| 4 |
Palo Alto Networks
PANW
|
+$574M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$405M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.33% |
| 2 | Financials | 13.77% |
| 3 | Healthcare | 12.44% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Bausch Health
BHC
$2.58B
| $6.79M | 0.01% |
985,301
+935,470
| +1,877% | +$6.5M |
|
1002
AstraZeneca
AZN
$263B
| $6.79M | 0.01% |
61,865
-49,399
| -44% | -$6.27M |
|
1003
Canadian Natural Resources
CNQ
$99.4B
| $6.76M | 0.01% |
290,556
+151,394
| +109% | +$3.92M |
|
1004
American Financial Group
AFG
$11.8B
| $6.75M | 0.01% |
54,907
+2,815
| +5% | +$369K |
|
1005
Murphy USA
MUSA
$11.2B
| $6.73M | 0.01% |
24,468
-31,586
| -56% | -$8.83M |
|
|
NEE.PRP
1006
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
| $6.7M | 0.01% |
134,595
+132,229
| +5,589% | +$6.91M |
|
1007
United Microelectronic
UMC
$47.7B
| $6.69M | 0.01% |
1,201,560
+398,461
| +50% | +$2.63M |
|
1008
US Foods
USFD
$22.2B
| $6.68M | 0.01% |
252,770
+178,038
| +238% | +$5.53M |
|
1009
Tencent Music
TME
$15.5B
| $6.68M | 0.01% |
1,645,511
+244,812
| +17% | +$1.11M |
|
1010
CareTrust REIT
CTRE
$9.91B
| $6.65M | 0.01% |
367,311
+100,875
| +38% | +$2.06M |
|
1011
Synaptics
SYNA
$4.19B
| $6.64M | 0.01% |
67,079
-22,115
| -25% | -$2.74M |
|
1012
PTC Therapeutics
PTCT
$5.68B
| $6.63M | 0.01% |
132,066
+108,178
| +453% | +$5.3M |
|
1013
Syndax Pharmaceuticals
SNDX
$1.69B
| $6.63M | 0.01% |
275,759
+271,168
| +5,907% | +$6.08M |
|
1014
Pinnacle West Capital
PNW
$12.2B
| $6.61M | 0.01% |
102,520
+19,550
| +24% | +$1.44M |
|
1015
PUT
Blackrock
BLK
$169B
| $6.6M | 0.01% |
+12,000
| New | +$7.85M |
|
1016
Coupang
CPNG
$29.3B
| $6.58M | 0.01% |
394,445
+71,420
| +22% | +$1.23M |
|
1017
Four Corners Property Trust
FCPT
$2.81B
| $6.58M | 0.01% |
271,788
-22,513
| -8% | -$618K |
|
|
AHRN
1018
DELISTED
Ahren Acquisition Corp
AHRN
| $6.53M | 0.01% |
650,000
| – | – |
|
|
SHAP
1019
DELISTED
Spree Acquisition Corp. 1 Limited
SHAP
| $6.53M | 0.01% |
646,576
| – | – |
|
1020
CNX Resources
CNX
$5.3B
| $6.53M | 0.01% |
420,377
-59,419
| -12% | -$1.01M |
|
1021
RPM International
RPM
$13.7B
| $6.5M | 0.01% |
77,993
+8,253
| +12% | +$733K |
|
1022
Dentsply Sirona
XRAY
$2.68B
| $6.48M | 0.01% |
228,720
+42,457
| +23% | +$1.45M |
|
1023
PUT
Marriott International
MAR
$98.3B
| $6.45M | 0.01% |
46,000
| – | – |
|
1024
Novavax
NVAX
$1.2B
| $6.45M | 0.01% |
354,220
+207,949
| +142% | +$9.01M |
|
1025
SiriusXM
SIRI
$9.98B
| $6.44M | 0.01% |
112,824
-39,322
| -26% | -$2.47M |
|
Similar funds
Barclays's Q3 2022 Portfolio in Review
As of Q3 2022, Barclays held 5,400 positions worth $91.6B, down 44% from $163B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $66.4B in Q3 2022, closing 533 positions and reducing 1,954 holdings. Its most notable exit was Vonage Holdings Corporation, an estimated $99.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Pacer iPath Gold ETNs worth $27.1M.
- Barclays's largest Q3 2022 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $27.1M.
- Barclays added most to Apple in Q3 2022, an estimated $1.44B increase.
- Barclays's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $873M.
- Barclays fully exited Vonage Holdings Corporation in Q3 2022, selling an estimated $99.4M.
- Barclays's ten largest holdings make up 22% of its $91.6B portfolio in Q3 2022.
- Barclays opened 261 new positions and closed 533 in Q3 2022.
- Barclays's portfolio value fell 44% quarter-over-quarter to $91.6B.
Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.